Dr. Jon Russell

Bruce Davidson is an Otolaryngologist in Washington, Washington, D.c.. Dr. Davidson is rated as a Distinguished provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Salivary Gland Tumors, Thyroid Cancer, Follicular Thyroid Cancer, Thyroidectomy, and Laryngectomy. Dr. Davidson is currently accepting new patients.

Dr. Katherine Day, originally from West Virginia, graduated with high honors from Princeton University and with highest honors from Yale University School of Medicine. She completed her residency in otolaryngology at the University of Maryland, where she managed to include prize-winning research with a busy clinical schedule. Dr. Day is board certified by the American Board of Otolaryngology. Dr. Day is rated as a Distinguished provider by MediFind in the treatment of Medullary Thyroid Carcinoma. Her top areas of expertise are Infant Hearing Loss, Jones Syndrome, DFNB1, Gastrostomy, and Endoscopy.

Dr. Tanguy Seiwert is an oncologist in Baltimore, caring for patients with head and neck cancer. He serves as the director of the Head and Neck Cancer Oncology Disease Program and the co-director of the Bloomberg~Kimmel Institute for Immunotherapy at the Head and Neck Cancer Program at the Johns Hopkins School of Medicine. Dr. Seiwert earned his M.D. at Johannes Gutenberg Universität in Mainz, Germany. He completed his residency at the Duke University School of Medicine and performed a fellowship in hematology/oncology at the University of Chicago Medicine Mitchell Hospital-Hyde Park. Dr. Seiwert joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Seiwert was director of the Head and Neck Cancer Program at the University of Chicago. Dr. Seiwert’s research interests include immunologic and genomic profiling. He has given numerous invited talks on head and neck cancer both nationally and internationally. Dr. Seiwert served as chief editor for Frontiers in Head and Neck Cancer and as an editorial board member for the Journal of Clinical Oncology and Oral Oncology. He is a reviewer for multiple medical journals, including Lancet Oncology, Annals of Oncology and Clinical Cancer Research. He has been recognized by the American Association for Clinical Oncology for multiple Merit Awards and a Young Investigator Award. He was a member of the NCI Head and Neck Cancer Steering Committee, and is a member of the American Association for Clinical Oncology, the Society for Immunotherapy of Cancer, and the European Society of Clinical Oncology. Dr. Seiwert is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Glioma, Laryngeal Cancer, Tongue Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy.